Craft

Alliqua

Revenue

$2.2 M

FY, 2018

Alliqua Summary

Company Summary

Overview
Alliqua BioMedical is a regenerative technologies company which commercializes regenerative medical products that assist the body in the repair or replacement of soft tissue. It markets MIST Ultrasound Healing Therapy, a painless, noncontact, low-frequency ultrasound to promote healing, Biovance Amniotic Membrane Allograft and Interfyl Human Connective Tissue Matrix that are human biologic regenerative technologies, and TheraBond 3D Antimicrobial Barrier Systems that promotes an optimal wound healing by creating an antimicrobial barrier that helps protect against infection. The company also provides contract manufacturing services, including the development, manufacture, and market of high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics.
Type
Subsidiary
Status
Closed
Founded
1997
HQ
Morrisville, PA, US | view all locations
Website
http://alliqua.com
Cybersecurity rating
Sectors

Key People

  • David Johnson

    David Johnson, CEO, and Member of the Board of Directors

  • Brad C. Barton
  • Brian Posner
  • Phillip Forman

    Phillip Forman, Executive VP Clinical Affairs

    LocationsView all

    1 location detected

    • Morrisville, PA HQ

      United States

      1010 Stony Hill Rd #200

    Alliqua Financials

    Summary Financials

    Net income (Q3, 2019)
    ($1.9M)
    Cash (Q3, 2019)
    $331.0K
    EBIT (Q3, 2019)
    ($1.7M)

    Footer menu